Correlagen Announces Launch of Expanded Cardiac Genetic Testing Services

WALTHAM, Mass.--(BUSINESS WIRE)--Correlagen today announced the launch of its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease. The CardioGeneScan tests for disease-causing variation in all genes known to be associated with familial cardiovascular diseases, including, cardiomyopathy, arrhythmia, thoracic aortic aneurysm, Noonan Syndrome and related diseases, and early-onset coronary artery disease. Due to its unprecedented breadth of testing, the CardioGeneScan has clinical utility for a wide range of patients with a family history of cardiac disease. Physicians will be able to assess the cardiac genetic make-up of their patients through a single test at a price that is affordable to their patients. More focused disease- or gene-specific testing is also available.